PolyActiva Pty Ltd.
- Home
- Companies
- PolyActiva Pty Ltd.
- Products
- Levofloxacin - Ocular Implant
Levofloxacin - Ocular Implant
Being developed to reduce the risk of Endophthalmitis following ocular (cataract) surgery. Clinical Investigation Stage: Phase I.
Most popular related searches
ocular implants
ocular implant
implant
drug administration
surgery clinical
clinical study
clinical trial
cataract surgery
ocular surgery
clinical stage
Micro implant. Maximum infection protection.
The Target Product Profile for the Levofloxacin Ocular Implant, currently under development, aims to deliver the following clinical benefits:
Early clinical studies (NCT04682288) conducted by PolyActiva have met clinical trial objectives. The Levofloxacin Ocular implant has not been approved by the U.S. Food and Drug Administration (FDA)